Postoperative surveillance of branch duct IPMN

Takao Ohtsuka, Masao Tanaka

研究成果: 著書/レポートタイプへの貢献

1 引用 (Scopus)

抄録

Surveillance protocol after resection of branch duct IPMNs (BD-IPMNs) is determined based on the following factors: (1) pathological grade of resected BD-IPMNs, (2) pancreatic margin status after partial pancreatectomy, (3) presence of the residual lesions left without resection in the remnant pancreas, (4) presence of concomitant PDACs at the time of operation, (5) the possibility of metachronous occurrence of BD-IPMNs, and (6) development of concomitant PDACs in the remnant pancreas. Yearly risk of PDAC development is reported to be 0.7-0.9 % in the patients with BD-IPMNs, and thus international consensus guidelines suggest that CT or MRCP at 6-month intervals is appropriate for surveillance after resection of BD-IPMNs, even though the resected IPMN is benign with negative surgical margin. Surveillance with shorter interval should be considered in patients who underwent resection of invasive IPMNs, who had positive surgical margin status, or who have significant clinical signs to suspect the progression or new development of the disease.

元の言語英語
ホスト出版物のタイトルIntraductal Papillary Mucinous Neoplasm of the Pancreas
出版者Springer Japan
ページ189-199
ページ数11
9784431544722
ISBN(電子版)9784431544722
ISBN(印刷物)4431544712, 9784431544715
DOI
出版物ステータス出版済み - 11 1 2014

Fingerprint

Pancreas
Pancreatectomy
Guidelines
Margins of Excision

All Science Journal Classification (ASJC) codes

  • Medicine(all)

これを引用

Ohtsuka, T., & Tanaka, M. (2014). Postoperative surveillance of branch duct IPMN. : Intraductal Papillary Mucinous Neoplasm of the Pancreas (巻 9784431544722, pp. 189-199). Springer Japan. https://doi.org/10.1007/978-4-431-54472-2_16

Postoperative surveillance of branch duct IPMN. / Ohtsuka, Takao; Tanaka, Masao.

Intraductal Papillary Mucinous Neoplasm of the Pancreas. 巻 9784431544722 Springer Japan, 2014. p. 189-199.

研究成果: 著書/レポートタイプへの貢献

Ohtsuka, T & Tanaka, M 2014, Postoperative surveillance of branch duct IPMN. : Intraductal Papillary Mucinous Neoplasm of the Pancreas. 巻. 9784431544722, Springer Japan, pp. 189-199. https://doi.org/10.1007/978-4-431-54472-2_16
Ohtsuka T, Tanaka M. Postoperative surveillance of branch duct IPMN. : Intraductal Papillary Mucinous Neoplasm of the Pancreas. 巻 9784431544722. Springer Japan. 2014. p. 189-199 https://doi.org/10.1007/978-4-431-54472-2_16
Ohtsuka, Takao ; Tanaka, Masao. / Postoperative surveillance of branch duct IPMN. Intraductal Papillary Mucinous Neoplasm of the Pancreas. 巻 9784431544722 Springer Japan, 2014. pp. 189-199
@inbook{8b74299a25674d37b411815093642991,
title = "Postoperative surveillance of branch duct IPMN",
abstract = "Surveillance protocol after resection of branch duct IPMNs (BD-IPMNs) is determined based on the following factors: (1) pathological grade of resected BD-IPMNs, (2) pancreatic margin status after partial pancreatectomy, (3) presence of the residual lesions left without resection in the remnant pancreas, (4) presence of concomitant PDACs at the time of operation, (5) the possibility of metachronous occurrence of BD-IPMNs, and (6) development of concomitant PDACs in the remnant pancreas. Yearly risk of PDAC development is reported to be 0.7-0.9 {\%} in the patients with BD-IPMNs, and thus international consensus guidelines suggest that CT or MRCP at 6-month intervals is appropriate for surveillance after resection of BD-IPMNs, even though the resected IPMN is benign with negative surgical margin. Surveillance with shorter interval should be considered in patients who underwent resection of invasive IPMNs, who had positive surgical margin status, or who have significant clinical signs to suspect the progression or new development of the disease.",
author = "Takao Ohtsuka and Masao Tanaka",
year = "2014",
month = "11",
day = "1",
doi = "10.1007/978-4-431-54472-2_16",
language = "English",
isbn = "4431544712",
volume = "9784431544722",
pages = "189--199",
booktitle = "Intraductal Papillary Mucinous Neoplasm of the Pancreas",
publisher = "Springer Japan",
address = "Japan",

}

TY - CHAP

T1 - Postoperative surveillance of branch duct IPMN

AU - Ohtsuka, Takao

AU - Tanaka, Masao

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Surveillance protocol after resection of branch duct IPMNs (BD-IPMNs) is determined based on the following factors: (1) pathological grade of resected BD-IPMNs, (2) pancreatic margin status after partial pancreatectomy, (3) presence of the residual lesions left without resection in the remnant pancreas, (4) presence of concomitant PDACs at the time of operation, (5) the possibility of metachronous occurrence of BD-IPMNs, and (6) development of concomitant PDACs in the remnant pancreas. Yearly risk of PDAC development is reported to be 0.7-0.9 % in the patients with BD-IPMNs, and thus international consensus guidelines suggest that CT or MRCP at 6-month intervals is appropriate for surveillance after resection of BD-IPMNs, even though the resected IPMN is benign with negative surgical margin. Surveillance with shorter interval should be considered in patients who underwent resection of invasive IPMNs, who had positive surgical margin status, or who have significant clinical signs to suspect the progression or new development of the disease.

AB - Surveillance protocol after resection of branch duct IPMNs (BD-IPMNs) is determined based on the following factors: (1) pathological grade of resected BD-IPMNs, (2) pancreatic margin status after partial pancreatectomy, (3) presence of the residual lesions left without resection in the remnant pancreas, (4) presence of concomitant PDACs at the time of operation, (5) the possibility of metachronous occurrence of BD-IPMNs, and (6) development of concomitant PDACs in the remnant pancreas. Yearly risk of PDAC development is reported to be 0.7-0.9 % in the patients with BD-IPMNs, and thus international consensus guidelines suggest that CT or MRCP at 6-month intervals is appropriate for surveillance after resection of BD-IPMNs, even though the resected IPMN is benign with negative surgical margin. Surveillance with shorter interval should be considered in patients who underwent resection of invasive IPMNs, who had positive surgical margin status, or who have significant clinical signs to suspect the progression or new development of the disease.

UR - http://www.scopus.com/inward/record.url?scp=84930891238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930891238&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-54472-2_16

DO - 10.1007/978-4-431-54472-2_16

M3 - Chapter

AN - SCOPUS:84930891238

SN - 4431544712

SN - 9784431544715

VL - 9784431544722

SP - 189

EP - 199

BT - Intraductal Papillary Mucinous Neoplasm of the Pancreas

PB - Springer Japan

ER -